ClinicalTrials.Veeva

Menu

Cost-Effectiveness and Outcome of Robot-assisted Vs Laparoscopic Roux-en-Y Gastric Bypass (LvRRYGB)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Morbid Obesity

Treatments

Device: Laparoscopic and robotic (DaVinci) RYGB

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this randomized controlled trial is to compare perioperative outcomes between laparoscopic and robotic approaches in patients with severe obesity who are candidates for RYGB. The trial aims to address the following key questions:

To evaluate the difference between the two procedures in terms of postoperative complications.

To assess intraoperative complications, conversion rate, mortality, operative times, postoperative hospital stay, and cost analysis for both approaches.

In summary, the researchers will compare the laparoscopic and robotic approaches to determine which one leads to better perioperative outcomes

Full description

Treating patients with pathological obesity has always posed a challenge for bariatric surgeons due to their increased risk of post-operative complications and varying short-term outcomes depending on the chosen procedure. Currently, there are no established guidelines to dictate which procedure is optimal for a given clinical presentation. Surgeons typically make this decision based on their expertise and the patient's characteristics. The most frequently performed procedures worldwide are sleeve gastrectomy and Roux-en-Y gastric bypass, with the latter validated by numerous long-term studies as a safe and effective bariatric and metabolic option for patients with a BMI <50 kg/m2. However, the complexity of Roux-en-Y gastric bypass, which requires the creation of two anastomoses during the reconstruction phase, which might be challenging when performed laparoscopically, may be facilitated by a robotic approach. Although some studies suggest that these approaches have equivalent safety and efficacy profiles, conclusive evidence evaluating their economic impact remains elusive. Consequently, the objective of the present study is to compare morbidity between the laparoscopic and robotic approach in patients undergoing Roux-en-Y gastric bypass.

Enrollment

512 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Patients who are candidates for Roux-en-Y gastric bypass using a minimally invasive technique
  • Informed consent has been given.

Exclusion criteria

  • patients who are candidates for bariatric procedures other than Roux-en-Y gastric bypass, or to those who require a laparotomy for Roux-en-Y gastric bypass surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

512 participants in 2 patient groups

Laparoscopic RYGB
Active Comparator group
Description:
Patients undergoing Roux-en-Y gastric bypass (RYGB) surgery performed laparoscopically.
Treatment:
Device: Laparoscopic and robotic (DaVinci) RYGB
Robotic RYGB
Experimental group
Description:
Patients undergoing Roux-en-Y gastric bypass (RYGB) surgery performed using the DaVinci robotic platform.
Treatment:
Device: Laparoscopic and robotic (DaVinci) RYGB

Trial contacts and locations

1

Loading...

Central trial contact

Marco Raffaelli, Prof.; Francesco Pennestrì, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems